Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
<p>Abstract</p> <p>Background</p> <p>The clinical data of plasma NVP level, safety and efficacy of antiretroviral therapy (ART) for the concurrent use of nevirapine (NVP)-based ART and fluconazole (FLU) is scanty.</p> <p>Methods</p> <p>A retrospe...
Main Authors: | Phoorisri Thanongsri, Uttayamakul Sumonmal, Athichathanabadi Chatiya, Manosuthi Weerawat, Sungkanuparph Somnuek |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-03-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/7/14 |
Similar Items
-
Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study
by: Chaovavanich Achara, et al.
Published: (2005-08-01) -
Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm<sup>3</sup>
by: Likanonsakul Sirirat, et al.
Published: (2007-03-01) -
Combined antiretroviral therapy with nevirapine of HIV-infected adults
by: A V Kravchenko
Published: (2004-11-01) -
Maternal deaths following nevirapine-based antiretroviral therapy
by: E Bera, et al.
Published: (2012-10-01) -
Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report
by: Yamazhan Tansu, et al.
Published: (2002-09-01)